Cardiovascular disease remains the leading cause of death in patients with diabetes.
Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk …

Smoking increases mortality from all causes and has a crucial role in atherosclerotic
cardiovascular disease (ASCVD). Active smoking and secondhand smoke exposure …

Background There is an increased burden of diabetes globally including in sub-Saharan
Africa. The literature shows that glycaemic control among type 2 diabetes patients is poor in …

Objectives COVID-19 and the implementation of lockdowns have impacted daily lives
worldwide. This systematic review and meta-analysis aimed to investigate the impact of …

Background We aimed to examine the association between smoking behavior change and
risk of cardiovascular disease (CVD) incidence and mortality in patients with type 2 diabetes …

Background Tobacco corporation Philip Morris International launched the Foundation for a
Smoke-Free World (FSFW), a purportedly independent scientific organisation, in 2017. We …

Smokers with diabetes mellitus substantially lower their risks of microvascular and
macrovascular diabetic complications, in particular cardiovascular disease, by quitting …

Introduction Smoking in people with diabetes markedly elevates their risk of develo**
complications and increases the likelihood of cardiovascular mortality. This review is the first …

The alarming rise in the worldwide prevalence of obesity and associated type 2 diabetes
mellitus (T2DM) have reached epidemic portions. Diabetes in its many forms and T2DM …

Abstract Purpose of Review Obesity is closely linked with the pathogenesis of type 2
diabetes (T2DM) and cardiovascular disease (CVD), and whilst smoking cessation is …